Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Both genders. 2) Willingness and ability to accept moxa intervention. 3) Patients diagnosed with Bronchial asthma using the Global Initiative for Asthma (GINA) guidelines
Exclusion criteria
Exclusion criteria: 1) Patients with diabetic neuropathy, severe cardiovascular diseases, cerebrovascular diseases, and chronic kidney diseases. 2) Patients allergy to Moxa. 3) People who are pregnant and lactating. 4) People with open wounds, skin infections.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary function test [Forced vital capacity (FVC), Forced expiratory volume (FEV1), Forced expiratory volume in 1s and Forced Vital Capacity ratio (FEV1/FVC), Forced expiratory flow (FEF), Peak expiratory flow rate (PEFR] will be assessed by using a spirometerTimepoint: Pulmonary Function Test will be assessed before and after the intervention period of 2 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Asthma Quality of Life Questionnaire (AQLQ)Timepoint: AQLQ will be assessed before and after the intervention period of 2 weeks | — |
Countries
India
Contacts
Government Yoga and Naturopathy Medical College and Hospital